Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Forum Sponsorship Forum Members (as of December 31, 2015) (as of December 31, 2015) Financial support for the Forum is derived from Membership in the Forum includes a private foundations, government agencies, industry diverse range of stakeholders from multiple sponsors, and nonprofit associations. sectors, including government, the phar- maceutical and biotechnology industries, Private Foundations Burroughs Wellcome Fund biomedical research funders and sponsors, Doris Duke Charitable Foundation academia, and patient groups. Other Nonprofit Organizations American Diabetes Association Russ Altman (Co-Chair) American Society for Microbiology Stanford University Association of American Medical Colleges Steven Galson (Co-Chair) Critical Path Institute Amgen Inc. FasterCures Friends of Cancer Research Margaret Anderson New England Journal of Medicine FasterCures Government Sponsors Hugh Auchincloss Center for Drug Evaluation and Research (FDA) National Institute of Allergy and Infectious Diseases National Cancer Institute (NIH) Christopher Austin National Center for Advancing Translational Sciences (NIH) National Center for Advancing Translational Sciences National Institute of Allergy and Infectious Diseases (NIH) Ann Bonham National Institute of Mental Health (NIH) Association of American Medical Colleges National Institute of Neurological Disorders and Stroke (NIH) Linda Brady Industry Sponsors National Institute of Mental Health AbbVie Amgen Inc. Gail Cassell AstraZeneca Harvard Medical School Department of Social and Baxalta Global Medicine (Visiting) Eli Lilly & Co. Andrew Dahlem GlaxoSmithKline Eli Lilly & Co. Johnson & Johnson James Doroshow Merck & Co., Inc. National Cancer Institute Pfizer Inc. Sanofi Jeffrey Drazen Takeda Pharmaceuticals New England Journal of Medicine Harry Greenberg Stanford University School of Medicine
Forum Sponsorship and Membership Lynn Hudson Elizabeth (Betsy) Myers Brian Strom Critical Path Institute Doris Duke Charitable Foundation Rutgers, the State University of S. Claiborne (Clay) Johnston Rajesh Ranganathan New Jersey Dell Medical School at the National Institute of Neurological Janet Tobias University of Texas, Austin Disorders and Stroke Ikana Health Jack Keene Robert Ratner John Wagner Duke University Medical Center American Diabetes Association Takeda Pharmaceuticals Rusty Kelley Michael Rosenblatt Joanne Waldstreicher Burroughs Wellcome Fund Merck & Co., Inc. Johnson & Johnson Ronald Krall Michael Severino Carrie Wolinetz University of Pittsburgh AbbVie NIH, Office of Science Policy Freda Lewis-Hall Ellen Sigal Janet Woodcock Pfizer Inc. Friends of Cancer Research FDA, Center for Drug Evaluation and Briggs Morrison Lana Skirboll Research AstraZeneca Sanofi Bernard Munos Murray Stewart InnoThink Center for Research in GlaxoSmithKline Biomedical Innovation Membership Patient Advocacy Government Foundations and 9% Associations 23% 8% Biotech/Other 3% Industry 17% Academia 29% Pharma 11% Miscellaneous Nonprofit
About the Forum on Drug Discovery, Development, and Translation About the National Academies of Sciences, Engineering, and Medicine The Forum on Drug Discovery, Development, and Translation of the The National Academy of Sciences was established in 1863 by an Act National Academies of Sciences, Engineering, and Medicine was created of Congress, signed by President Lincoln, as a private, nongovernmental in 2005 by the Academiesâ Board on Health Sciences Policy to provide a institution to advise the nation on issues related to science and technol- unique platform for dialogue and collaboration among thought leaders ogy. Members are elected by their peers for outstanding contributions to and stakeholders in government, academia, industry, foundations, and research. Dr. Ralph J. Cicerone is president. patient advocacy with an interest in improving the system of drug dis- The National Academy of Engineering was established in 1964 under covery, development, and translation. The Forum brings together leaders the charter of the National Academy of Sciences to bring the practices of from private-sector sponsors of biomedical and clinical research, federal engineering to advising the nation. Members are elected by their peers agencies sponsoring and regulating biomedical and clinical research, the for extraordinary contributions to engineering. Dr. C. D. Mote, Jr., is academic community, and patients, and in doing so serves to educate the president. policy community about issues where science and policy intersect. The National Academy of Medicine (formerly the Institute of Medicine) The Forum convenes several times each year to identify and discuss key was established in 1970 under the charter of the National Academy of problems and strategies in the discovery, development, and translation of Sciences to advise the nation on medical and health issues. Members are drugs. To supplement the perspectives and expertise of its members, the elected by their peers for distinguished contributions to medicine and Forum also holds public workshops to engage a wide range of experts, health. Dr. Victor J. Dzau is president. members of the public, and the policy community. The Forum also fosters collaborations among its members and constituencies. For more information The three Academies work together as the National Academies of about the Forum on Drug Discovery, Development, and Translation, please Sciences, Engineering, and Medicine to provide independent, objective visit our website at www.hmd.nationalacademies.org/drug. analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The Academies also Forum Staff encourage education and research, recognize outstanding contributions Anne B. Claiborne, J.D., M.P.H. Morgan L. Boname, M.S. to knowledge, and increase public understanding in matters of science, Senior Program Officer and Forum (as of December 2015) engineering, and medicine. Director Associate Program Officer Christopher J. DeFeo, Ph.D. Kathryn M. Howell Learn more about the National Academies of Sciences, Engineering, and (until October 2015) (until November 2015) Medicine at www.national-academies.org. Program Officer Senior Program Assistant Rebecca A. English, M.P.H. Olivia C. Yost, M.S. Program Officer (as of December 2015) Amanda Wagner Gee, M.S. Senior Program Assistant (as of November 2015) Board on Health Sciences Policy Program Officer Andrew M. Pope, Ph.D. Emily R. Busta, M.S. Director (until December 2015) Associate Program Officer
